Exodus Point Capital Management, LP Regeneron Pharmaceuticals, Inc. Transaction History

Exodus Point Capital Management, LP

$9.1 Billion
Q3 2025

A detailed history of Exodus Point Capital Management, LP transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 27,732 shares of REGN stock, worth $19.2 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

27,732

Holding current value

$19.2 Million

% of portfolio

0.17%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$534.91 - $598.71 $14.8 Million - $16.6 Million	27,732 New	27,732 $15.6 Million
Q4 2024 Feb 12, 2025	SELL	$701.85 - $1046.91 $4.95 Million - $7.38 Million	-7,047 Reduced 90.72%	721 $514,000
Q3 2024 Nov 12, 2024	BUY	$1024.09 - $1201.76 $4.39 Million - $5.15 Million	4,282 Added 122.83%	7,768 $8.17 Million
Q2 2024 Aug 13, 2024	SELL	$883.2 - $1071.19 $8.64 Million - $10.5 Million	-9,785 Reduced 73.73%	3,486 $3.66 Million
Q1 2024 May 14, 2024	BUY	$902.69 - $993.35 $12 Million - $13.2 Million	13,271 New	13,271 $12.8 Million

Q2 2023 Aug 10, 2023	SELL	$700.03 - $830.35 $20.3 Million - $24.1 Million	-28,975 Reduced 91.02%	2,858 $2.05 Million
Q1 2023 May 11, 2023	BUY	$680.49 - $826.97 $8.69 Million - $10.6 Million	12,777 Added 67.05%	31,833 $26.2 Million
Q4 2022 Feb 13, 2023	BUY	$705.89 - $766.39 $13.5 Million - $14.6 Million	19,056 New	19,056 $13.7 Million
Q3 2022 Nov 10, 2022	SELL	$573.97 - $724.32 $3.67 Million - $4.63 Million	-6,390 Closed	0 $0
Q2 2022 Aug 19, 2022	BUY	$548.35 - $738.84 $3.5 Million - $4.72 Million	6,390 New	6,390 $3.78 Million
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $1.14 Million - $1.34 Million	-1,918 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$543.48 - $670.97 $427,175 - $527,382	786 Added 69.43%	1,918 $1.21 Million
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $324,900 - $385,423	-566 Reduced 33.33%	1,132 $685,000
Q2 2021 Aug 16, 2021	SELL	$472.8 - $558.54 $7.12 Million - $8.41 Million	-15,064 Reduced 89.87%	1,698 $948,000
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $4.03 Million - $4.95 Million	9,032 Added 116.84%	16,762 $7.93 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $2.31 Million - $2.94 Million	4,840 Added 167.47%	7,730 $3.73 Million
Q3 2020 Nov 16, 2020	BUY	$544.75 - $658.21 $1.57 Million - $1.9 Million	2,890 New	2,890 $1.62 Million
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $1.22 Million - $1.59 Million	-2,469 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $830,028 - $1.22 Million	2,469 New	2,469 $1.21 Million
Q1 2019 May 15, 2019	SELL	$372.08 - $439.57 $1.79 Million - $2.11 Million	-4,803 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $1.61 Million - $1.94 Million	4,803 New	4,803 $1.79 Million

Others Institutions Holding REGN

# of Institutions

1,490

Shares Held

86.4M

Call Options Held

2.38M

Put Options Held

1.61M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Account

Exodus Point Capital Management, LP Regeneron Pharmaceuticals, Inc. Transaction History